Expansion platform type II: testing a treatment strategy.
about
Clinical Trials in the Genomic Era.Novel Targeted Therapies for Esophagogastric Cancer.Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.How can next-generation diagnostics aid pancreatic adenocarcinoma treatment?Targeted therapies for targeted populations: Anti-EGFR treatment for EGFR amplified gastroesophageal adenocarcinoma.
P2860
Expansion platform type II: testing a treatment strategy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 September 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expansion platform type II: testing a treatment strategy.
@en
Expansion platform type II: testing a treatment strategy.
@nl
type
label
Expansion platform type II: testing a treatment strategy.
@en
Expansion platform type II: testing a treatment strategy.
@nl
prefLabel
Expansion platform type II: testing a treatment strategy.
@en
Expansion platform type II: testing a treatment strategy.
@nl
P2860
P1433
P1476
Expansion platform type II: testing a treatment strategy.
@en
P2093
Daniel V T Catenacci
P2860
P304
P356
10.1016/S1470-2045(15)00224-7
P577
2015-09-02T00:00:00Z